Details for New Drug Application (NDA): 019269
✉ Email this page to a colleague
NDA 019269 describes VENTOLIN, which is a drug marketed by Glaxosmithkline and is included in seven NDAs. Additional details are available on the VENTOLIN profile page.
The generic ingredient in VENTOLIN is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
The generic ingredient in VENTOLIN is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
Summary for 019269
| Tradename: | VENTOLIN |
| Applicant: | Glaxosmithkline |
| Ingredient: | albuterol sulfate |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INHALATION | Strength | EQ 0.5% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jan 16, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
